Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Completed × Behavior, Addictive × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1130 Carcinoma, Non-Small-Cell Lung 801 Prostatic Neoplasms 651 Neoplasms 541 Lymphoma 476 Multiple Myeloma 475 Colorectal Neoplasms 473 Lung Neoplasms 470 Leukemia 432 Neoplasm Metastasis 415 Leukemia, Myeloid, Acute 409 Melanoma 382 Lymphoma, Non-Hodgkin 365 Ovarian Neoplasms 357 Leukemia, Lymphocytic, Chronic, B-Cell 335 Pancreatic Neoplasms 328 Recurrence 299 Precursor Cell Lymphoblastic Leukemia-Lymphoma 277 Head and Neck Neoplasms 266 Glioblastoma 264 Lymphoma, Large B-Cell, Diffuse 259 Brain Neoplasms 256 Stomach Neoplasms 254 Myelodysplastic Syndromes 249 Lymphoma, Follicular 248 Carcinoma, Renal Cell 234 Carcinoma, Hepatocellular 229 Rectal Neoplasms 227 Hodgkin Disease 227 Sarcoma 222

Interventions

Varenicline 1 Tobacco Use Cessation Devices 1 Nicotine Chewing Gum 1 Bupropion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04634071 2026-02-02

TTOP

University of Kentucky

Phase 2 Completed

Smoking Cessation, Neoplasms, Second Primary, Behavior, Addictive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡